# Methotrexate

## Methotrexate inj 50mg/2mL

| TAH Drug Code      | [**IMTX2**](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=IMTX2)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|:-------------------|:---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Trophoblastic tumors, leukemia, lymphoma, osteogenic & bronchogenic carcinoma, breast, head & neck cancer, mycosis fungoides.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
| Dosing             | [Choriocarcinoma and similar trophoblastic diseases] 15-30 mg orally or intramuscularly daily for a 5-day course repeated for 3-5 times as required with rest periods of 1 or more weeks interposed between courses until any manifesting toxic symptoms subside. [Breast cancer] 40 mg/m2 IV on days 1 and 8 in combination with cyclophosphamide and fluorouracil. [Leukemia] Induction: 3.3 mg/m2 in combination with prednisolone 60 mg/m2 daily for 4-6 weeks. Maintenance therapy: administer 2 times weekly orally or IM in total weekly doses of 30 mg/m2 or 2.5 mg/kg IV every 14 days. If and when relapse occurs, repeat initial induction regimen. [Meningeal Leukemia] 0.2-0.5 mg/kg intrathecally at intervals of 2-5 days until the cell count of the cerebrospinal fluid returns to normal. At this point one additional dose is advisable. Alternative: 12 mg/m2 intrathecally once weekly for 2 weeks, then once monthly. [Lymphomas] 0.625-2.5 mg/kg daily. Treatment in all stages usually consists of several courses interposed with 7-10 day rest periods. 0.625-2.5 mg/kg daily.[Mycosis fungoides] 50 mg IM once weekly or 25 mg IM twice weekly. |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
| Renal Impairment   | Dose adjustment required                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| Contraindications  | Pregnancy & lactation. Psoriatic patient in a poor state of nutrition, serious renal or liver disorders, bone marrow hyperplasia, leukopenia, thrombocytopenia or anemia.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
| Adverse Effects    | Hepatotoxicity, GI, dermatological, liver & GUT toxicity.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
| Pregnancy          | Contraindicated                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
| Lactation          | Contraindicated                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |

## Methotrexate 2.5mg

| TAH Drug Code      | [**OMTX**](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=OMTX)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|:-------------------|:---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Oncology uses: Acute lymphoblastic leukemia (ALL) maintenance treatment, ALL meningeal leukemia (preservative-free only; prophylaxis and treatment); treatment of trophoblastic neoplasms (gestational choriocarcinoma, chorioadenoma destruens and hydatidiform mole), breast cancer, head and neck cancer (epidermoid), cutaneous T-Cell lymphoma (advanced mycosis fungoides), lung cancer (squamous cell and small cell), advanced non-Hodgkin lymphomas (NHL), osteosarcoma (preservative-free only). Nononcology uses: Treatment of psoriasis (severe, recalcitrant, disabling) that is unresponsive to other therapies; severe, active rheumatoid arthritis (RA) that is unresponsive to or intolerant of first-line therapy including full dose nonsteroidal anti-inflammatory agents (NSAIDs); active polyarticular-course juvenile idiopathic arthritis (pJIA) that is unresponsive to or intolerant of first-line therapy including full dose nonsteroidal anti-inflammatory agents (NSAIDs). Off-Label: Abortion (medical management); Acute graft-versus-host disease (prophylaxis); Acute promyelocytic leukemia (APL) maintenance (adults); Bladder cancer; CNS lymphoma; Crohn disease (maintenance of remission); Dermatomyositis/polymyositis; Ectopic pregnancy; Multiple sclerosis; Nonleukemic meningeal cancer; Soft tissue sarcoma (desmoid tumors, aggressive fibromatosis), advanced; Systemic lupus erythematosus, moderate-to-severe; Takayasu arteritis, refractory or relapsing disease; Uveitis (adults) |
| Dosing             | [Choriocarcinoma and similar trophoblastic diseases] 15-30 mg orally or IM daily for a 5-day course. Repeat 3-5 times as required with rest periods of 1 or more weeks interposed between courses, until any manifesting toxic symptoms subside. [Leukemia] Induction: 3.3 mg/m2 in combination with prednisone 60 mg/m2 daily for 4-6 weeks. Maintenance therapy: orally or IM 2 times weekly intotal weekly doses of 30 mg/m2 or 2.5 mg/kg intravenously every 14 days. If and when relapse occurs, repeat the initial induction regimen. [Lymphomas] 10-25 mg/day orally for 4-8 days. Treatment in all stages usually consists of several courses interposed with 7-10 day rest periods. Lymphosarcomas in Stage III may respond to combined drug therapy with 0.625-2.5 mg/kg daily. [Psoriasis] 10-25 mg orally, IM or IV once weekly or 2.5 mg orally at 12-hour intervals for 3 doses every 1 week until adequate response is achieved. 30 mg/week should not ordinarily be exceeded.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| Renal Impairment   | Dose adjustment required                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
| Contraindications  | Known hypersensitivity to methotrexate or any component of the formulation; breast-feeding. Additional contraindications for patients with psoriasis, rheumatoid arthritis or polyarticular-course juvenile idiopathic arthritis: Pregnancy, alcoholism, alcoholic liver disease or other chronic liver disease, immunodeficiency syndromes (overt or laboratory evidence); preexisting blood dyscrasias (eg, bone marrow hypoplasia, leukopenia, thrombocytopenia, significant anemia).                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
| Adverse Effects    | Ulcerative stomatitis, leukopenia, nausea & abdominal distress. malaise, fatigue, chills & fever, dizziness & decreased resistance to infection. Erythematous rashes, pruritus, urticaria, photosensitivity, depigmentation, alopecia, ecchymosis, telangiectasia, acne & furunculosis. Hematologic disorders. GI disturbances. CNS effects. Metabolic changes, precipitating diabetes, osteoporosis, conjunctivitis, abnormal tissue cell changes, anaphylaxis.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| Pregnancy          | Contraindicated â€“ 1st Trimester                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
| Lactation          | Contraindicated                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |

